IRIDEX to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020
February 28 2020 - 04:03PM
IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will
release financial results for the fourth quarter and full year of
2019 after the close of trading on Thursday, March 12, 2020.
The Company’s management team will host a corresponding conference
call beginning at 2:00 p.m. PT / 5:00 p.m. ET.
Investors interested in listening to the conference call may do
so by dialing (844) 707-0665 for domestic callers or (703) 326-3030
for international callers, using conference ID: 6384497. A
live and archived webcast of the event will be available on the
“Investors” section of the Company’s website at:
www.iridex.com.
About IRIDEXIRIDEX Corporation is a worldwide
leader in developing, manufacturing, and marketing innovative and
versatile laser-based medical systems, delivery devices and
consumable instrumentation for the ophthalmology market. The
Company’s proprietary MicroPulse® technology delivers a
differentiated treatment that provides safe, effective, and proven
treatment for targeted sight-threatening eye conditions. IRIDEX’s
current product line is used for the treatment of glaucoma and
diabetic macular edema (DME) and other retinal diseases. IRIDEX
products are sold in the United States through a direct sales force
and internationally primarily through a network of independent
distributors into more than 100 countries. For further information,
visit the IRIDEX website at www.iridex.com.
Investor Relations Contact: Leigh Salvo (415)
937-5404 investors@iridex.com
Media Contact: Jamie Hall Pascale
Communications, LLC. (724) 417-0167 pr@iridex.com
IRIDEX (NASDAQ:IRIX)
Historical Stock Chart
From Feb 2024 to Mar 2024
IRIDEX (NASDAQ:IRIX)
Historical Stock Chart
From Mar 2023 to Mar 2024